EUVIMEDEUVIMED entdecken
Crossref

Impact of Dose Adjustment After Gaps in Subcutaneous Immunotherapy: Update From the North American Immunotherapy Surveillance Study (2008-2023)

Tolly G Epstein, Karen Berendts, David I Bernstein

The Journal of Allergy and Clinical Immunology: In Practice · 2026

DOI: 10.1016/j.jaip.2025.10.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026. Verfasst von Tolly G Epstein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology, Allergy, and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Allergy Pa…. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Allergens, Hypersensitivity. Die Arbeit nennt 16 Literaturangaben. Gefördert von: American Academy of Allergy Asthma and Immunology, American College of Allergy Asthma & Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Protocols for adjusting allergy injection doses after gaps in therapy, and optimal intervals for maintenance injections, are based on expert opinion only. OBJECTIVE: To assess (1) incidences of systemic allergic reactions (SRs) to subcutaneous allergen immunotherapy (SCIT), (2) clinical practices that reduce the risk of SRs, (3) SCIT-related infections, and (4) risks associated with interruptions in SCIT. METHODS: From 2008 to 2023, members of the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma, & Immunology completed annual surveys of SCIT-related SRs; SCIT-related infections were assessed since 2014. Questions were added in 2020 regarding dose adjustment after gaps in immunotherapy, and maintenance intervals prescribed. RESULTS: Data were gathered on 84.1 million injection visits and 4.9 million patients (2008-2023). Four new SCIT-related fatalities were confirmed (2018-2023). One contaminated vial, resulting in 2 local skin infections, was identified (2014-2023). Practices reducing to 1 vial lower in patients who were more than 7 weeks late for maintenance vial injections had fewer grade 4 SRs (P = .02). Practices decreasing to the next lower vial in patients who were more than 28 days late during buildup had fewer grade 3 and 4 SRs (P = .03). For the period from 2021 to 2022, there was an increased rate of total (P < .0001), grade 2 (P < .0001), and grade 3 SRs (P = .0005) for practices that used a maintenance injection interval longer than 4 weeks. CONCLUSIONS: Fatal reactions to SCIT still rarely occur. The risk of infections from SCIT is extremely low. Controlled studies are needed to define optimal dose adjustment strategies after gaps in therapy as well as the safest, most efficacious maintenance intervals for aeroallergen SCIT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desensitization, ImmunologicAllergensHypersensitivityHumansInjections, SubcutaneousMaleFemaleAdultNorth AmericaMiddle AgedUnited StatesIncidence

Stichwörter der Autor:innen

Gaps in therapyMaintenance intervalsSubcutaneous allergen immunotherapySystemic reactions

Substanzen

Allergens

Autor:innen und Institutionen

  • Division of Immunology, Allergy, and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Allergy Partners of Central Indiana, Indianapolis, Ind. Electronic address: epst…
  • Bernstein Clinical Research Center, LLC, Cincinnati, Ohio.
  • Division of Immunology, Allergy, and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Bernstein Clinical Research Center, LLC, Cincinnati, Ohio.

Förderung

  • American Academy of Allergy Asthma and Immunology
  • American College of Allergy Asthma & Immunology

Zitieren

APA

Epstein, T. G., Berendts, K., & Bernstein, D. I. (2026). Impact of Dose Adjustment After Gaps in Subcutaneous Immunotherapy: Update From the North American Immunotherapy Surveillance Study (2008-2023). The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2025.10.026

Vancouver

Epstein TG, Berendts K, Bernstein DI. Impact of Dose Adjustment After Gaps in Subcutaneous Immunotherapy: Update From the North American Immunotherapy Surveillance Study (2008-2023). The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2025.10.026

BibTeX
@article{Epstein2026,
  author = {Epstein, Tolly G and Berendts, Karen and Bernstein, David I},
  title = {Impact of Dose Adjustment After Gaps in Subcutaneous Immunotherapy: Update From the North American Immunotherapy Surveillance Study (2008-2023)},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2026},
  doi = {10.1016/j.jaip.2025.10.026}
}
Kostenlos starten →